Elucidation of Artemisinin as a Potent GSK3β Inhibitor for Neurodegenerative Disorders via Machine Learning-Driven QSAR and Virtual Screening of Natural Compounds
<b>Background/Objectives:</b> Glycogen synthase kinase-3 beta (GSK3β) is a key enzyme involved in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, contributing to tau hyperphosphorylation, amyloid-beta (Aβ) aggregation, and neuronal dysfunction. <b>Methods</b>:...
Saved in:
| Main Authors: | Hassan H. Alhassan, Malvi Surti, Mohd Adnan, Mitesh Patel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/826 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artemisinin resistance, some facts and opinions
by: Antonella Pantaleo, et al.
Published: (2015-07-01) -
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01) -
Glandular trichomes: the factory of artemisinin biosynthesis
by: Qiaojuan Zhao, et al.
Published: (2024-01-01) -
Chemical proteomics approach reveals the direct targets and the heme-dependent activation mechanism of artemisinin in Plasmodium falciparum using an activity-based artemisinin probe
by: Jigang Wang, et al.
Published: (2016-04-01) -
Two distinct and competitive pathways confer the cellcidal actions of artemisinins
by: Chen Sun, et al.
Published: (2015-01-01)